Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Articles

Page Path
HOME > Diabetes Metab J > Volume 30(5); 2006 > Article
Original Article Current Status of Aspirin User in Korean Diabetic Patients Using Korean Health Insurance Database.
Ie Byung Park, Dae Jung Kim, Jaiyong Kim, Hyeyoung Kim, Hwayoung Kim, Kyung Wan Min, Seok Won Park, Jeong Hyun Park, Sei Hyun Baik, Hyun Shik Son, Chul Woo Ahn, Jee Young Oh, Sunhee Lee, Juneyoung Lee, Choon Hee Chung, Injeoung Choi, Kyung Mook Choi
Diabetes & Metabolism Journal 2006;30(5):363-371
DOI: https://doi.org/10.4093/jkda.2006.30.5.363
Published online: September 1, 2006
  • 2,745 Views
  • 34 Download
  • 7 Crossref
  • 0 Scopus
1Task Force Team for Basic Statistical Study of Korean Diabetes Mellitus of Korean Diabetes Association, Korea.
2Department of Research, Health Insurance Review Agency, Korea.
3Department of Endocrinology, Gachon University of Science and Medicine, Gil Medical Center, Korea.
4Department of Endocrinology and Metabolism, Ajou University School of Medicine, Korea.
5Department of Internal Medicine, College of Medicine, Eulji University, Korea.
6Department of Internal Medicine, Pochon CHA University, Korea.
7Department of Internal Medicine, Pusan Paik Hospital, Inje College of Medicine, Korea.
8Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University, Korea.
9Department of Internal Medicine, The Catholic University of Korea, Korea.
10Department of Internal Medicine, Yonsei University College of Medicine, Korea.
11Division of Endocrinology and Metabolism, Ewha Womans University College of Medicine, Korea.
12Department of Biostatistics, College of Medicine, Korea University, Korea.
13Department of Internal Medicine, Wonju College of Medicine, Yonsei University, Korea.
prev next

AIMS: ADA guidelines recommend aspirin for all patients with diabetes who have had a prior CHD events as well as a primary prevention strategy among those with at least one other risk factor. We examined the current status of regular aspirin intake among Korean adults who diagnosed as diabetes. METHODS: This study examined the characteristics of aspirin user in new-onset diabetes over 40 years based on health insurance claims submitted to the Health Insurance Review Agency (HIRA) of Korea during the period from January 2001 through December 2003. New onset diabetes defined as the first health insurance claim of antidiabetic drugs submitted to HIRA for the three months (January to March 2001) that never submitted for previous 6 years. RESULTS: The number of total new-onset diabetic patients was 30,014 in 2001, 29,819 in 2002, and 32,061 in 2003. The incidence rate of diabetes over 40 years for 3 months in 2001, 2002 and 2003 were 0.172%, 0.167% and 0.18. Mean age of women who diagnosed diabetes were significant higher than that of men in 2001 (women 59.2+/-10.6 yrs, men 54.8+/-9.8 yrs), in 2002 (women 59.5+/-10.6 yrs, men 54.6+/-9.3 yrs) and in 2003 (women 59.6+/-10.7 yrs, men 54.7+/-9.9 yrs) (p < 0.001). The number of aspirin user increased from 2,065 (6.9%) in 2001, 2,638 (8.9%) in 2002 and 3,711 (11.6%) in 2003. 30.5% of new-onset diabetics in 2001 had hypertension, 12.4% of them had hypercholesterolemia, 11.8% of them had cerebral infarct, 2.6% of them had cerebral hemorrhage, 3.8% of them had coronary heart disease and, but, 55.6% of them had not any CVD. Logistic regression analysis using aspirin use as a dependent variable showed that the number of aspirin use in patients with hypertension, hypercholesterolemia, cerebral infarct and coronary heart disease was higher than in patients without those (hypertension [OR], 3.89 (95% CI, 3.52~4.31); hypercholesterolemia [OR], 2.16 (95% CI, 1.90~2.46; cerebral infarct [OR], 2.05 (95% CI, 1.82~2.30); coronary heart disease [OR], 9.41 (95% CI, 8.20~10.80), respectively). Coronary heart disease was the most important associated factor of aspirin use. CONCLUSIONS: We found significant underuse of aspirin therapy among our population compared with that of America. Major efforts are needed to increase aspirin use in diabetic patients.

  • Cite
    CITE
    export Copy
    Close
    Download Citation
    Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

    Format:
    • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
    • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
    Include:
    • Citation for the content below
    Current Status of Aspirin User in Korean Diabetic Patients Using Korean Health Insurance Database.
    Korean Diabetes J. 2006;30(5):363-371.   Published online September 1, 2006
    Close
Related articles
Park IB, Kim DJ, Kim J, Kim H, Kim H, Min KW, Park SW, Park JH, Baik SH, Son HS, Ahn CW, Oh JY, Lee S, Lee J, Chung CH, Choi I, Choi KM. Current Status of Aspirin User in Korean Diabetic Patients Using Korean Health Insurance Database.. Diabetes Metab J. 2006;30(5):363-371.
DOI: https://doi.org/10.4093/jkda.2006.30.5.363.

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP